Biotransformation of Glycyrrhetinic Acid by Cunninghamella blakesleeana

Salari, 2001, Antibacterial effect of glycyrrhetinic acid on 55 hospital strains of staphylococcus aureus and 32 actinobacillus actinomycetemcomitans [J], J Faculty Pharm, 9, 37 Nabekura, 2008, Inhibition of P-glyco-protein and multidrug resistance protein 1 by dietary phytochemicals [J], Cancer Chemother Pharmacol, 62, 867, 10.1007/s00280-007-0676-4 Maitraie, 2009, Synthesis, anti-inflammatory, and antioxidant activities of 18β-glycyrrhetinic acid derivatives as chemical mediators and xanthine oxidase inhibitors [J], Bioorgan Med Chem, 17, 2786, 10.1016/j.bmc.2009.02.025 Liu, 2007, The synthesis of 18β-glycyrrhetinic acid derivatives which have increased antiproliferative and apoptotic effects in leukemia cells [J], Bioorgan Med Chem, 15, 5432, 10.1016/j.bmc.2007.05.057 Davis, 1991, Medicinal uses of licorice through the millennia: The good and plenty of it [J], Mol Cell Endocrinol, 78, 1, 10.1016/0303-7207(91)90179-V Xin, 2006, Microbial transformation of glycyrrhetinic acid by mucor polymorphosporus [J], Planta Med, 72, 156, 10.1055/s-2005-873198 Xin, 2010, Structural determination of two new triterpenoids biotransformed from glycyrrhetinic acid by Mucor polymorphosporus [J], Magn Reson Chem, 48, 164, 10.1002/mrc.2552 Huang, 2009, Biotransformation of glycyrrhizin by Aspergillus niger [J], Biocatal Biotransfor, 27, 1, 10.1080/10242420902722435 Galal, 2010, Bioactive microbial metabolites from glycyrrhetinic acid [J], Phyto-chemistry, 71, 262 Davis, 1988, Microbial models of mammalian drug metabolism: [J], Dev Ind Microbiol, 29, 197 Moody, 2002, Biotransformation of mirtazapine by Cunninghamella elegans [J], Drug Metab Dispos, 30, 1274, 10.1124/dmd.30.11.1274 Manosroi, 2007, A novel one-step biotransformation of cortexolone-21-acetate to hydrocorti-sone acetate using Cunninghamella blakesleeana ATCC 8688a [J], Enzyme Microb Tech, 41, 322, 10.1016/j.enzmictec.2007.02.014 Ning, 2003, Biotransformation of triptolide by Cunninghamella blakesleana [J], Tetrahedron, 59, 4209, 10.1016/S0040-4020(03)00605-7 Zhang, 2007, Four novel metabolites from microbial transformation of curcumol by Cunninghamella blakesleana [J], Chem Pharm Bull, 55, 451, 10.1248/cpb.55.451 Grignon, 2002, Validation of diffusion methods for macrolide susceptibility testing of Helicobacter pylori [J], Microb Drug Resist, 8, 61, 10.1089/10766290252913773 Sun, 2009, Fungal biotransformation of mosapride by Cunninghamella elegans [J], J Mol Catal B: Enzymatic, 59, 82, 10.1016/j.molcatb.2009.01.009 Asha, 2009, Cunninghamella–A microbial model for drug metabolism studies–A review [J], Biotechnol Adv, 27, 16, 10.1016/j.biotechadv.2008.07.005